Similar articles

• Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.

  Weiss HJ. Weiss HJ. Am Heart J. 1976 Jul;92(1):86-102. doi: 10.1016/s0002-8703(76)80408-5. Am Heart J. 1976. PMID: 785989 Review. No abstract available.
• The current status of platelet suppressive drugs in the treatment of thrombosis.

  Hirsh J, Gent M, Genton E. Hirsh J, et al. Thromb Diath Haemorrh. 1975 Jun 30;33(3):406-16. Thromb Diath Haemorrh. 1975. PMID: 1098213 Clinical Trial. No abstract available.
• Antiplatelet agents: rationale and results.

  Kelton JG. Kelton JG. Clin Haematol. 1983 Feb;12(1):311-54. Clin Haematol. 1983. PMID: 6132693 Review. No abstract available.
• Platelet function inhibitors: their clinical use.

  Fuster V, Didisheim P. Fuster V, et al. Adv Intern Med. 1978;23:251-64. Adv Intern Med. 1978. PMID: 343540 Review. No abstract available.
• [Summary: Drugs affecting platelet behaviour; experimental and clinical data (author's transl)].

  Bouvier CA. Bouvier CA. Ther Umsch. 1974 Feb;31(2):84-8. Ther Umsch. 1974. PMID: 4612856 Review. French. No abstract available.